These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11574202)

  • 1. Non-antimicrobial activities of macrolides.
    Williams JD
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S89-91. PubMed ID: 11574202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
    Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
    Respiration; 2011; 81(1):67-74. PubMed ID: 20733281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of macrolide antibiotics on gastrointestinal motility in fasting and digestive states.
    Nakayoshi T; Izumi M; Tatsuta K
    Drugs Exp Clin Res; 1992; 18(4):103-9. PubMed ID: 1451641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory properties of antibiotics.
    Tauber SC; Nau R
    Curr Mol Pharmacol; 2008 Jan; 1(1):68-79. PubMed ID: 20021425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on effects of 14- and 16-membered macrolides on gastrointestinal motility in unanaesthetized dogs.
    Nakayoshi T; Izumi M; Shinkai S; Fujita M
    Drugs Exp Clin Res; 1988; 14(5):319-25. PubMed ID: 3265375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics as biological response modifiers.
    Rubin BK; Tamaoki J
    Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M; Henke MO; Rubin BK
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review.
    Kovaleva A; Remmelts HH; Rijkers GT; Hoepelman AI; Biesma DH; Oosterheert JJ
    J Antimicrob Chemother; 2012 Mar; 67(3):530-40. PubMed ID: 22190609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonantibiotic properties of macrolides and their role in modulation of the inflammatory reaction].
    Zupanets IA; Tkachenko EM; Sakharova TS
    Eksp Klin Farmakol; 2012; 75(12):41-5. PubMed ID: 23700669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Antibiotic Use in COPD and the Potential Anti-Inflammatory Activities of Antibiotics.
    Huckle AW; Fairclough LC; Todd I
    Respir Care; 2018 May; 63(5):609-619. PubMed ID: 29463692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial macrolides: a drug class with a complex pharmacological profile.
    Abu-Gharbieh E; Vasina V; Poluzzi E; De Ponti F
    Pharmacol Res; 2004 Sep; 50(3):211-22. PubMed ID: 15225662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolides in cystic fibrosis.
    Bell SC; Senini SL; McCormack JG
    Chron Respir Dis; 2005; 2(2):85-98. PubMed ID: 16279156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry of the immunomodulatory macrolide ascomycin and related analogues.
    Bulusu MA; Baumann K; Stuetz A
    Prog Chem Org Nat Prod; 2011; 94():59-126. PubMed ID: 21833838
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrolides for the treatment of chronic sinusitis, asthma, and COPD.
    Gotfried MH
    Chest; 2004 Feb; 125(2 Suppl):52S-60S; quiz 60S-61S. PubMed ID: 14872001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolides: present and future. An appraisal of in-vitro activity and pharmacokinetic behavior.
    Furneri PM; Nicoletti G
    J Chemother; 1991 Jan; 3 Suppl 1():24-7. PubMed ID: 12041776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourteen-membered ring macrolides as anti-angiogenic compounds.
    Yatsunami J; Hayashi S
    Anticancer Res; 2001; 21(6B):4253-8. PubMed ID: 11908678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis.
    Cervin A; Wallwork B
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1339-50. PubMed ID: 16326189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.